Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Person writing with pen

Brexpiprazole versus placebo or other antidepressive agents for treating depression

Ralovska S. et al, (2023), Cochrane Database of Systematic Reviews, 2023

The indirect relationship between sleep and cognition in the PREVENT Cohort: Identifying targets for intervention

Tari B. et al, (2023)

Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife.

Dounavi M-E. et al, (2023), J Cereb Blood Flow Metab

Insulin resistance, age and depression’s impact on cognition in middle-aged adults from the PREVENT cohort

Bauermeister SD. et al, (2023), BMJ Mental Health, 26, e300665 - e300665

Insulin Resistance's Impact on Cognition in Middle Aged Adults from the PREVENT cohort: Interactive Effects with Depression

Bauermeister S. et al, (2023)

Barriers to brain health behaviours: results from the Five Lives Brain Health Ireland Survey.

Dukelow T. et al, (2023), Front Psychol, 14

Ethical challenges of using remote monitoring technologies for clinical research: A case study of the role of local research ethics committees in the RADAR-AD study.

Muurling M. et al, (2023), PLoS One, 18

Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach.

Koychev I. et al, (2023), PLoS One, 18

Neurodegenerative disease of the brain: a survey of interdisciplinary approaches

Davenport F. et al, (2023), Journal of the Royal Society, Interface, 20

Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.

Low A. et al, (2022), Alzheimers Res Ther, 14

Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.

Dounavi M-E. et al, (2022), J Neurol, 269, 4299 - 4309

Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model.

Liu Q. et al, (2022), BMC Med, 20

Modifiable risk factors for dementia, and awareness of brain health behaviors: Results from the Five Lives Brain Health Ireland Survey (FLBHIS).

Dukelow T. et al, (2022), Front Psychol, 13

Neurons derived from individual early Alzheimer's disease patients reflect their clinical vulnerability.

Ng B. et al, (2022), Brain Commun, 4

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study.

Sen A. et al, (2021), Trials, 22

An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): A Double-Blind, Placebo Controlled, Randomised Cross Over Proof of Concept Study

Sen A. et al, (2021)

Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives.

Rogers JP. et al, (2021), J Neurol Neurosurg Psychiatry

Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis

Badenoch J. et al, (2021)

Remote monitoring technologies in Alzheimer's disease: design of the RADAR-AD study.

Muurling M. et al, (2021), Alzheimers Res Ther, 13

The neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives

Rogers J. et al, (2021)

Load More

Include forthcoming?